These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Levodopa in Forbes-Albright syndrome. Flückiger E; Del Pozo E Can Med Assoc J; 1973 Mar; 108(5):554. PubMed ID: 4689553 [No Abstract] [Full Text] [Related]
3. Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): restoration of ovulatory function and fertility. Varga L; Wenner R; Del Pozo E Am J Obstet Gynecol; 1973 Sep; 117(1):75-9. PubMed ID: 4722381 [No Abstract] [Full Text] [Related]
4. [Prolactin and galactorrhea]. Villa JG; Salto L Rev Clin Esp; 1973 Feb; 128(3):183-94. PubMed ID: 4572951 [No Abstract] [Full Text] [Related]
5. Two-bromo- -ergocryptine (CB 154) inhibition of prolactin secretion and galactorrhoea in a case of pituitary tumour. Copinschi G; L'Hermite M; Pasteels JL; Robyn C Gynecol Invest; 1971; 2(1):128-9. PubMed ID: 5170651 [No Abstract] [Full Text] [Related]
7. [The role of prolactin in disturbances of the menstrual cycle]. Wenner R Gynecologie; 1974; 25(2):229-31. PubMed ID: 4448266 [No Abstract] [Full Text] [Related]
8. [Galactorrhea in the woman]. Leutenegger M; Audibert A; Caron J; Renard A Schweiz Rundsch Med Prax; 1972 Jun; 61(23):762-6. PubMed ID: 4672085 [No Abstract] [Full Text] [Related]
9. Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea. Beumont P; Bruwer J; Pimstone B; Vinik A; Utian W Br J Psychiatry; 1975 Mar; 126():285-8. PubMed ID: 236061 [No Abstract] [Full Text] [Related]
10. Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes. Del Pozo E; Varga L; Wyss H; Tolis G; Friesen H; Wenner R; Vetter L; Uettwiler A J Clin Endocrinol Metab; 1974 Jul; 39(1):18-26. PubMed ID: 4209685 [No Abstract] [Full Text] [Related]
11. [Inhibition of lactation with 2 Br-alpha-ergocryptine]. Jaszmann L; Szabó E; Szontágh F Orv Hetil; 1974 Sep; 115(35):2053-4. PubMed ID: 4603634 [No Abstract] [Full Text] [Related]
13. [Inhibition of prolactin by an ergot-alkaloid derivative]. Wenner R; Varga L Gynakol Rundsch; 1973; 13():Suppl 1:64-5. PubMed ID: 4798936 [No Abstract] [Full Text] [Related]
14. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine). Del Pozo E; Del Re RB; Varga L; Friesen H J Clin Endocrinol Metab; 1972 Nov; 35(5):768-71. PubMed ID: 4672297 [No Abstract] [Full Text] [Related]
15. Treatment of non-puerperal galactorrhoea with an ergot alkaloid. Lutterbeck PM; Pryor JS; Varga L; Wenner R Br Med J; 1971 Jul; 3(5768):228-9. PubMed ID: 5105219 [TBL] [Abstract][Full Text] [Related]
16. The effect of levodopa on galactorrhea in the Forbes-Albright syndrome. Edmonds M; Friesen H Can Med Assoc J; 1972 Sep; 107(6):534 passim. PubMed ID: 5066538 [No Abstract] [Full Text] [Related]
17. Ergonovine therapy of nonpuerperal galactorrhea. Lawrence AM; Hagen TC N Engl J Med; 1972 Jul; 287(3):150. PubMed ID: 5064142 [No Abstract] [Full Text] [Related]
18. [Galactorrhea; diagnostic and therapeutic aspects]. Verhoeven AT Ned Tijdschr Geneeskd; 1974 Jun; 118(23):864-72. PubMed ID: 4857777 [No Abstract] [Full Text] [Related]
19. [Advances in the treatment of the galactorrhoea-amenorrhoea-syndrome: Induction of ovulation and inhibition of lactation with 2-Br-alpha-ergo-cryptine (author's transl)]. Jaszmann L; Sternthal V Geburtshilfe Frauenheilkd; 1974 Jan; 34(1):59-64. PubMed ID: 4816922 [No Abstract] [Full Text] [Related]